Peripheral neuropathies and anti-glycolipid antibodies
The DOI matches its Crossref record; 296 of the 296 references it cites were found in a registry or an index.
Abstract
This review charts the progress of anti-glycolipid antibodies in neuropathy, from their original discovery 20 years ago in immunoglobulin M paraproteinaemic neuropathy through to current discoveries mapping their relationship to subtypes of Guillain-Barré syndrome. Antibodies to >20 different glycolipids have now been associated with a wide range of clinically identifiable acute and chronic neuropathy syndromes. Particular progress has been achieved in understanding the link between acute motor axonal neuropathy and antibodies to GM1, GD1a, GM1b and GalNAc-GD1a, and between the cranial, bulbar and sensory variants of GBS and antibodies to the disialylated gangliosides GQ1b, GT1a, GD1b and GD3. In addition to clinical and serological studies, the origins and measurement of anti-glycolipid antibodies and their relationships to similar carbohydrate structures on infectious organisms, particularly Campylobacter jejuni, are discussed in the context of a molecular mimicry hypothesis. The structure and nomenclature of relevant glycolipids are outlined, along with information on their localization in nerve, and the influence this has on clinical phenotypes. Major advances have been made in animal modelling of anti-glycolipid antibody-associated diseases, both in vitro and in vivo. This has advanced our understanding of the role of anti-GQ1b antibodies in Miller Fisher syndrome with particular respect to the motor nerve terminal as a potential site of injury, and led to the creation of rabbit models of anti-GD1b and anti-GM1 antibody-mediated sensory and motor neuropathy, respectively. With such information in place, it will now be possible to determine the precise mechanisms by which antibodies injure the different compartments of peripheral nerve and establish how a range of immunomodulating therapies, including current treatments, exert their therapeutic effects. Despite these very significant advances, considerable gaps in our knowledge persist, and it is likely that other pathogenic pathways operate in inflammatory neuropathy that are unrelated to glycolipid antibodies, although these are outside the scope of this review.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the latter instance rare human immune responses against the ganglioside-like structures can even result in serious illness, with the complementfi xing antibodies damaging peripheral nerves (Guillain-Barré syndrome) (990 -991).”
From Biological roles of glycans (2017) · cites this paper as [990]
Citations
Cites
Functional rafts in cell membranes
Simons, K., & Ikonen, E. (1997) · Nature · doi:10.1038/42408 · Cited by 9,757
van der Meché, F. G. A., Schmitz, P. I. M., & the Dutch Guillain–Barré Study Group* (1992) · New England Journal of Medicine · doi:10.1056/nejm199204233261705 · Cited by 1,143
Fisher, M. (1956) · New England Journal of Medicine · doi:10.1056/nejm195607122550201 · Cited by 1,069
Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcome
Hadden, R. D. M., Cornblath, D. R., Hughes, R. A. C., Zielasek, J., Hartung, H. ‐., Toyka, K. V., Swan, A. V., & The Plasma Exchange/Sandoglobulin Guillain‐Barré Syndrome Trial Group (1998) · Annals of Neurology · doi:10.1002/ana.410440512 · Cited by 942
The spectrum of antecedent infections in Guillain-Barré syndrome: A case-control study
Jacobs, B. C., Rothbarth, P. H., van der Meché, F. G. A., Herbrink, P., Schmitz, P. I. M., de Klerk, M. A., & van Doorn, P. A. (1998) · Neurology · doi:10.1212/wnl.51.4.1110 · Cited by 826
Defining criteria for autoimmune diseases (Witebsky's postulates revisited)
Rose, N. R., & Bona, C. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90244-f · Cited by 814
Campylobacter jejuni Infection and Guillain–Barré Syndrome
Rees, J. H., Soudain, S. E., Gregson, N. A., & Hughes, R. A. C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511233332102 · Cited by 753
THE INFLAMMATORY LESION IN IDIOPATHIC POLYNEURITIS
ASBURY, A. K., ARNASON, B. G., & ADAMS, R. D. (1969) · Medicine · doi:10.1097/00005792-196905000-00001 · Cited by 723
Chiba, A., Kusunoki, S., Obata, H., Machinami, R., & Kanazawa, I. (1993) · Neurology · doi:10.1212/wnl.43.10.1911 · Cited by 705
[10] Gangliosides: Structure, isolation, and analysis
Ledeen, R. W., & Yu, R. K. (1982) · Methods in Enzymology · doi:10.1016/0076-6879(82)83012-7 · Cited by 701
Acute motor axonal neuropathy: A frequent cause of acute flaccid paralysis in China
McKhann, G. M., Cornblath, D. R., Griffin, J. W., Ho, T. W., Li, C. Y., Jiang, Z., Wu, H. S., Zhaori, G., Liu, Y., Jou, L. P., et al. (1993) · Annals of Neurology · doi:10.1002/ana.410330402 · Cited by 625
(1997) · Transfusion Medicine Reviews · doi:10.1016/s0887-7963(97)80059-4 · Cited by 610
A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside
Pestronk, A., Cornblath, D. R., Ilyas, A. A., Baba, H., Quarles, R. H., Griffin, J. W., Alderson, K., & Adams, R. N. (1988) · Annals of Neurology · doi:10.1002/ana.410240113 · Cited by 609
Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome
Chiba, A., Kusunoki, S., Shimizu, T., & Kanazawa, I. (1992) · Annals of Neurology · doi:10.1002/ana.410310619 · Cited by 562
AN ACUTE AXONAL FORM OF GUILLAIN-BARRÉE POLYNEUROPATHY
FEASBY, T. E., GILBERT, J. J., BROWN, W. F., BOLTON, C. F., HAHN, A. F., KOOPMAN, W. F., & ZOCHODNE, D. W. (1986) · Brain · doi:10.1093/brain/109.6.1115 · Cited by 538
Acute motor axonal neuropathy: An antibody‐mediated attack on axolemma
Hafer‐Macko, C., Hsieh, S., Ho, T. W., Sheikh, K., Cornblath, D. R., Li, C. Y., McKhann, G. M., Asbury, A. K., & Griffin, J. W. (1996) · Annals of Neurology · doi:10.1002/ana.410400414 · Cited by 512
Yuki, N., Taki, T., Inagaki, F., Kasama, T., Takahashi, M., Saito, K., Handa, S., & Miyatake, T. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.5.1771 · Cited by 504
Multifocal demyelinating neuropathy with persistent conduction block
Lewis, R. A., Sumner, A. J., Brown, M. J., & Asbury, A. K. (1982) · Neurology · doi:10.1212/wnl.32.9.958 · Cited by 502
Acute axonal polyneuropathy associated with anti‐GM 1 antibodies following Campylobacter enteritis
Yuki, N., Yoshino, H., Sato, S., & Miyatake, T. (1990) · Neurology · doi:10.1212/wnl.40.12.1900 · Cited by 477
Clinical and Epidemiologic Features of Guillain‐Barré Syndrome
Hughes, R. A. C., & Rees, J. H. (1997) · The Journal of Infectious Diseases · doi:10.1086/513793 · Cited by 456
Chou, D. K., Ilyas, A. A., Evans, J. E., Costello, C., Quarles, R. H., & Jungalwala, F. B. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67303-x · Cited by 436
Immune attack on the schwann cell surface in acute inflammatory demyelinating polyneuropathy
Hafer‐Macko, C. E., Sheikh, K. A., Li, C. Y., Ho, T. W., Cornblath, D. R., McKhann, G. M., Asbury, A. K., & Griffin, J. W. (1996) · Annals of Neurology · doi:10.1002/ana.410390512 · Cited by 416
T-Independent Immune Response: New Aspects of B Cell Biology
Fagarasan, S., & Honjo, T. (2000) · Science · doi:10.1126/science.290.5489.89 · Cited by 413
Pathogenesis of Guillain–Barré syndrome
Hughes, R. A. C., Hadden, R. D. M., Gregson, N. A., & Smith, K. J. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00195-2 · Cited by 405
Pathology of the motor‐sensory axonal Guillain‐Barré syndrome
Griffin, J. W., Li, C. Y., Ho, T. W., Tian, M., Gao, C. Y., Xue, P., Mishu, B., Cornblath, D. R., Macko, C., McKhann, G. M., et al. (1996) · Annals of Neurology · doi:10.1002/ana.410390105 · Cited by 403
Motor unit physiology: Some unresolved issues
Enoka, R. M., & Fuglevand, A. J. (2001) · Muscle & Nerve · doi:10.1002/1097-4598(200101)24:1<4::aid-mus13>3.0.co;2-f · Cited by 390
Anti-GQ1b IgG antibody syndrome: clinical and immunological range
Odaka, M. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.1.50 · Cited by 388
Ganglioside Stimulation of Axonal Sprouting in Vitro
Roisen, F. J., Bartfeld, H., Nagele, R., & Yorke, G. (1981) · Science · doi:10.1126/science.7291999 · Cited by 386
Ogawara, K., Kuwabara, S., Mori, M., Hattori, T., Koga, M., & Yuki, N. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200010)48:4<624::aid-ana9>3.3.co;2-f · Cited by 333
Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barr� syndrome
Ho, T. W., Willison, H. J., Nachamkin, I., Li, C. Y., Veitch, J., Ung, H., Wang, G. R., Liu, R. C., Cornblath, D. R., Asbury, A. K., et al. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199902)45:2<168::aid-ana6>3.0.co;2-6 · Cited by 329
Self-citationYuki, N., Yamada, M., Koga, M., Odaka, M., Susuki, K., Tagawa, Y., Ueda, S., Kasama, T., Ohnishi, A., Hayashi, S., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1012 · Cited by 323
Knee extensor strength, activation, and size in very elderly people following strength training
Harridge, S. D. R., Kryger, A., & Stensgaard, A. (1999) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199907)22:7<831::aid-mus4>3.0.co;2-3 · Cited by 322
Dodd, J., & Jessell, T. (1985) · The Journal of Neuroscience · doi:10.1523/jneurosci.05-12-03278.1985 · Cited by 315
Ariga, T., Kohriyama, T., Freddo, L., Latov, N., Saito, M., Kon, K., Ando, S., Suzuki, M., Hemling, M. E., & Rinehart, K. L. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)75864-5 · Cited by 314
Latov, N., Sherman, W. H., Nemni, R., Galassi, G., Shyong, J. S., Penn, A. S., Chess, L., Olarte, M. R., Rowland, L. P., & Osserman, E. F. (1980) · New England Journal of Medicine · doi:10.1056/nejm198009113031105 · Cited by 314
Campylobacter jejuni infections and anti‐GM1 antibodies in guillain‐barré syndrome
Jacobs, B. C., van Doorn, P. A., Tio‐Gillen, A. P., Visser, L. H., van der Meché, F. G. A., Schmitz, P. I. M., Herbrink, P., & Hooijkaas, H. (1996) · Annals of Neurology · doi:10.1002/ana.410400209 · Cited by 314
Kuwabara, S., Yuki, N., Koga, M., Hattori, T., Matsuura, D., Miyake, M., & Noda, M. (1998) · Annals of Neurology · doi:10.1002/ana.410440210 · Cited by 311
Myelin‐Associated Glycoprotein Is the Antigen for a Monoclonal IgM in Polyneuropathy
Braun, P. E., Frail, D. E., & Latov, N. (1982) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1982.tb12563.x · Cited by 304
Willison, H. J. (2001) · Brain · doi:10.1093/brain/124.10.1968 · Cited by 297
Self-citationImmunopathogenesis and treatment of the guillain‐barré syndrome—part I
Hartung, H., Toyka, K. V., Pollard, J. D., & Harvey, G. K. (1995) · Muscle & Nerve · doi:10.1002/mus.880180202 · Cited by 288
Chiba, A., Kusunoki, S., Obata, H., Machinami, R., & Kanazawa, I. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01123-7 · Cited by 288
Multifocal acquired demyelinating neuropathy masqurading as motor neuron disease
Parry, G. J., & Clarke, S. (1988) · Muscle & Nerve · doi:10.1002/mus.880110203 · Cited by 286
Leger, J.-M., Chassande, B., Musset, L., Meininger, V., Bouche, P., & Baumann, N. (2001) · Brain · doi:10.1093/brain/124.1.145 · Cited by 279
Nobile‐Orazio, E., Manfredini, E., Carpo, M., Meucci, N., Monaco, S., Ferrari, S., Bonetti, B., Cavaletti, G., Gemignani, F., Durelli, L., et al. (1994) · Annals of Neurology · doi:10.1002/ana.410360313 · Cited by 277
Serum antibodies to gangliosides in guillain‐barré syndrome
Ilyas, A. A., Willison, H. J., Quarles, R. H., Jungalwala, F. B., Cornblath, D. R., Trapp, B. D., Griffin, D. E., Griffin, J. W., & McKhann, G. M. (1988) · Annals of Neurology · doi:10.1002/ana.410230503 · Cited by 272
Self-citationRees, J. H., Gregson, N. A., & Hughes, R. A. C. (1995) · Annals of Neurology · doi:10.1002/ana.410380516 · Cited by 266
Weiner, H. L., Lemere, C. A., Maron, R., Spooner, E. T., Grenfell, T. J., Mori, C., Issazadeh, S., Hancock, W. W., & Selkoe, D. J. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200010)48:4<567::aid-ana3>3.0.co;2-w · Cited by 263
Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome
Griffin, J. W., Li, C. Y., Macko, C., Ho, T. W., Hsieh, S. T., Xue, P., Wang, F. A., Cornblath, D. R., McKhann, G. M., & Asbury, A. K. (1996) · Journal of Neurocytology · doi:10.1007/bf02284784 · Cited by 262
Association between Campylobacter Infection and Guillain‐Barré Syndrome
Allos, B. M. (1997) · The Journal of Infectious Diseases · doi:10.1086/513783 · Cited by 261
Mesencephalitis and Rhombencephalitis
Bickerstaff, E. R., & Cloake, P. C. P. (1951) · BMJ · doi:10.1136/bmj.2.4723.77 · Cited by 257
Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside.
Willison, H. J., Veitch, J., Paterson, G., & Kennedy, P. G. (1993) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.2.204 · Cited by 257
Self-citationUnusual Clinical Variants and Signs in Guillain-Barre Syndrome
Ropper, A. H. (1986) · Archives of Neurology · doi:10.1001/archneur.1986.00520110044012 · Cited by 254
Hays, A. P., Latov, N., Takatsu, M., & Sherman, W. H. (1987) · Neurology · doi:10.1212/wnl.37.2.242 · Cited by 251
IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab
Levine, T. D., & Pestronk, A. (1999) · Neurology · doi:10.1212/wnl.52.8.1701 · Cited by 250
Kuroki, S., Saida, T., Nukina, M., Haruta, T., Yoshioka, M., Kobayashi, Y., & Nakanishi, H. (1993) · Annals of Neurology · doi:10.1002/ana.410330304 · Cited by 247
Takigawa, T., Yasuda, H., Kikkawa, R., Shigeta, Y., Saida, T., & Kitasato, H. (1995) · Annals of Neurology · doi:10.1002/ana.410370405 · Cited by 245
Bickerstaff, E. R. (1957) · BMJ · doi:10.1136/bmj.1.5032.1384 · Cited by 240
Nobile-Orazio, E. (2000) · Brain · doi:10.1093/brain/123.4.710 · Cited by 237
Tatum, A. H. (1993) · Annals of Neurology · doi:10.1002/ana.410330514 · Cited by 230
Visser, L. H., van der Meche, F. G. A., Meulstee, J., Rothbarth, P., Jacobs, B. C., Schmitz, P. I. M., & van Doorn, P. A. (1996) · Neurology · doi:10.1212/wnl.47.3.668 · Cited by 224
Experimental Allergic Neuritis Induced by Sensitization with Galactocerebroside
Saida, T., Saida, K., Dorfman, S. H., Silberberg, D. H., Sumner, A. J., Manning, M. C., Lisak, R. P., & Brown, M. J. (1979) · Science · doi:10.1126/science.451555 · Cited by 217
Goodyear, C. S., O’Hanlon, G. M., Plomp, J. J., Wagner, E. R., Morrison, I., Veitch, J., Cochrane, L., Bullens, R. W. M., Molenaar, P. C., Conner, J., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6837 · Cited by 210
Self-citationAspinall, G. O., McDonald, A. G., Pang, H., Kurjanczyk, L. A., & Penner, J. L. (1994) · Biochemistry · doi:10.1021/bi00167a032 · Cited by 210
BRAINSTEM ENCEPHALITIS AND THE SYNDROME OF MILLER FISHER A CLINICAL STUDY
AL-DIN, A. N., ANDERSON, M., BICKERSTAFF, E. R., & HARVEY, I. (1982) · Brain · doi:10.1093/brain/105.3.481 · Cited by 207
Gangliosides GM1 and GD1b are antigens for IgM M-protein in a patientwith motor neuron disease
(1986) · Neurology · doi:10.1212/wnl.36.4.454 · Cited by 207
Frequent presence of anti‐G Q1b antibody in Fisher's syndrome
Yuki, N., Sato, S., Tsuji, S., Ohsawa, T., & Miyatake, T. (1993) · Neurology · doi:10.1212/wnl.43.2.414 · Cited by 204
Guillain-Barré syndrome and Campylobacter jejuni: a serological study.
Kaldor, J., & Speed, B. R. (1984) · BMJ · doi:10.1136/bmj.288.6434.1867 · Cited by 204
Experimental sensory neuropathy induced by sensitization with ganglioside GD1b
Kusunoki, S., Shimizu, J., Chiba, A., Ugawa, Y., Hitoshi, S., & Kanazawa, I. (1996) · Annals of Neurology · doi:10.1002/ana.410390404 · Cited by 199
Illa, I., Ortiz, N., Gallard, E., Juarez, C., Grau, J. M., & Dalakas, M. C. (1995) · Annals of Neurology · doi:10.1002/ana.410380214 · Cited by 196
Miller Fisher anti-GQ1b antibodies: ?-Latrotoxin-like effects on motor end plates
Plomp, J. J., Molenaar, P. C., O'Hanlon, G. M., Jacobs, B. C., Veitch, J., Daha, M. R., Van Doorn, P. A., Van Der Mech�, F. G. A., Vincent, A., Morgan, B. P., et al. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199902)45:2<189::aid-ana9>3.0.co;2-t · Cited by 196
Self-citationO'Hanlon, G. M. (2001) · Brain · doi:10.1093/brain/124.5.893 · Cited by 192
Self-citationExperimental conduction block induced by serum from a patient with anti‐GM1 antibodies
Santoro, M., Uncini, A., Corbo, M., Staugaitis, S. M., Thomas, F. P., Hays, A. P., & Latov, N. (1992) · Annals of Neurology · doi:10.1002/ana.410310407 · Cited by 190
Ho, T. W., Hsieh, S.-T., Nachamkin, I., Willison, H. J., Sheikh, K., Kiehlbauch, J., Flanigan, K., McArthur, J. C., Cornblath, D. R., McKhann, G. M., et al. (1997) · Neurology · doi:10.1212/wnl.48.3.717 · Cited by 187
Self-citationChassande, B., L�ger, J.-M., Younes-Chennoufi, A. B., Bengoufa, D., Maisonobe, T., Bouche, P., & Baumann, N. (1998) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199801)21:1<55::aid-mus8>3.0.co;2-f · Cited by 184
Ilyas, A. A., Quarles, R. H., Dalakas, M. C., Fishman, P. H., & Brady, R. O. (1985) · Annals of Neurology · doi:10.1002/ana.410180605 · Cited by 184
Latov, N., Hays, A. P., Donofrio, P. D., H. Ito, J. L., McGinnis, S., Manoussos, K., Freddo, L., Shy, M. E., Sherman, W. H., Chang, H. W., et al. (1988) · Neurology · doi:10.1212/wnl.38.5.763 · Cited by 183
Dodd, J., Solter, D., & Jessell, T. M. (1984) · Nature · doi:10.1038/311469a0 · Cited by 180
N‐acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain‐Barré syndrome
Kusunoki, S., Chiba, A., Kon, K., Ando, S., Arisawa, K., Tate, A., & Kanazawa, I. (1994) · Annals of Neurology · doi:10.1002/ana.410350510 · Cited by 180
Ledeen, R. (1985) · Trends in Neurosciences · doi:10.1016/0166-2236(85)90064-5 · Cited by 176
An immunologic abnormality common to Bickerstaff's brain stem encephalitis and Fisher's syndrome
Yuki, N., Sato, S., Tsuji, S., Hozumi, I., & Miyatake, T. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90250-3 · Cited by 172
Yuki, N., Taki, T., Takahashi, M., Saito, K., Yoshino, H., Tai, T., Handa, S., & Miyatake, T. (1994) · Annals of Neurology · doi:10.1002/ana.410360517 · Cited by 172
Enders, U., Karch, H., Toyka, K. V., Michels, M., Zielasek, J., Pette, M., Heesemann, J., & Hartung, H. (1993) · Annals of Neurology · doi:10.1002/ana.410340208 · Cited by 171
Invited review: Motor neuropathies, motor neuron disorders, and antiglycolipid antibodies
Md, A. P. (1991) · Muscle & Nerve · doi:10.1002/mus.880141002 · Cited by 171
Mujoo, K., Kipps, T. J., Yang, H., Cheresh, D. A., WARGALLA, U., Sander, D. J., & Reisfeld, R. A. (1989) · PubMed · Cited by 169
The immunopathogenesis of Miller Fisher syndrome
Willison, H. J., & O’Hanlon, G. M. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00213-1 · Cited by 167
Self-citationPhase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma.
Saleh, M. N., Khazaeli, M. B., Wheeler, R. H., Dropcho, E. J., Liu, T., Urist, M. M., Miller, D. M., Lawson, S., Dixon, P., & RUSSELL, C. H. (1992) · PubMed · Cited by 160
Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia
Kusunoki, S., Chiba, A., & Kanazawa, I. (1999) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199908)22:8<983::aid-mus1>3.0.co;2-v · Cited by 157
Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia
Kusunoki, S., Chiba, A., & Kanazawa, I. (1999) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199908)22:8<1071::aid-mus10>3.0.co;2-0 · Cited by 156
Ilyas, A. A., Mithen, F. A., Dalakas, M. C., Chen, Z.-W., & Cook, S. D. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90217-9 · Cited by 155
Wan, X. S. T., Trojanowski, J. Q., & Gonatas, J. O. (1982) · Brain Research · doi:10.1016/0006-8993(82)90244-x · Cited by 155
Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release
Roberts, M. T. M., Vincent, A. C., Newsom–Davis, J., & Willison, H. J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92694-8 · Cited by 151
Self-citationLongitudinal study of skeletal muscle adaptations during immobilization and rehabilitation
Vandenborne, K., Elliott, M. A., Walter, G. A., Abdus, S., Okereke, E., Shaffer, M., Tahernia, D., & Esterhai, J. L. (1998) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199808)21:8<1006::aid-mus4>3.0.co;2-c · Cited by 151
Koski, C. L., Humphrey, R. L., & Shin, M. L. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.3.905 · Cited by 150
Vriesendorp, F. J., Mishu, B., Blaser, M. J., & Koski, C. L. (1993) · Annals of Neurology · doi:10.1002/ana.410340206 · Cited by 150
Myelin glycolipids and their functions
Stoffel, W., & Bosio, A. (1997) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(97)80085-2 · Cited by 148
Walsh, F. S., Cronin, M., Koblar, S. A., Doherty, P., Winer, J. B., Leon, A. A. G., & Hughes, R. A. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90097-q · Cited by 148
The distribution of ganglioside-like moieties in peripheral nerves
Sheikh, K. A., Deerinck, T. J., Ellisman, M. H., & Griffin, J. W. (1999) · Brain · doi:10.1093/brain/122.3.449 · Cited by 145
Designation and Schematic Structure of Gangliosides and Allied Glycosphingolipids
Svennerholm, L. T. (1994) · Progress in brain research · doi:10.1016/s0079-6123(08)61935-4 · Cited by 144
Saida, K., Saida, T., Brown, M. J., & Silberberg, D. H. (1979) · PubMed · Cited by 143
Anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: Evidence of molecular mimicry
Kusunoki, S., Shiina, M., & Kanazawa, I. (2001) · Neurology · doi:10.1212/wnl.57.4.736 · Cited by 142
Autoantibodies associated with peripheral neuropathy
Quarles, R. H., & Weiss, M. D. (1999) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199907)22:7<800::aid-mus2>3.0.co;2-f · Cited by 142
Inter‐laboratory validation of an ELISA for the determination of serum anti‐ganglioside antibodies
Willison, H. J., Veitch, J., Swan, A. V., Baumann, N., Comi, G. C., Gregson, N. A., IIIa, I., Jacobs, B. C., Zielasek, J., & Hughes, R. A. (1999) · European Journal of Neurology · doi:10.1046/j.1468-1331.1999.610071.x · Cited by 140
Self-citationSevere acute axonal form of Guillain–Barré syndrome associated with IgG anti‐GD1a antibodies
Yuki, N., Yoshino, H., Sato, S., Shinozawa, K., & Miyatake, T. (1992) · Muscle & Nerve · doi:10.1002/mus.880150806 · Cited by 138
Fredman, P., Vedeler, C. A., Nyland, H., Aarli, J. A., & Svennerholm, L. T. (1991) · Journal of Neurology · doi:10.1007/bf00315684 · Cited by 136
The clinical correlates of high‐titer IgG anti‐GM1 antibodies
Kornberg, A. J., Pestronk, A., Bieser, K., Ho, T. W., McKhann, G. M., Wu, H. S., & Jiang, Z. (1994) · Annals of Neurology · doi:10.1002/ana.410350217 · Cited by 135
The sensitivity and specificity of anti-GM sub 1 antibody testing
Taylor, B. V., Gross, L., & Windebank, A. J. (1996) · Neurology · doi:10.1212/wnl.47.4.951 · Cited by 135
Willison, H. J., Trapp, B. D., Bacher, J. D., Dalakas, M. C., Griffin, J. W., & Quarles, R. H. (1988) · Muscle & Nerve · doi:10.1002/mus.880111111 · Cited by 134
Self-citationDiagnostic value of GM 1 antibodies in motor neuron disorders and neuropathies: A meta-analysis
van Schaik, I. N., Bossuyt, P. M., Brand, A., & Vermeulen, M. (1995) · Neurology · doi:10.1212/wnl.45.8.1570 · Cited by 134
Paparounas, K., O'Hanlon, G. M., O'Leary, C. P., Rowan, E. G., & Willison, H. J. (1999) · Brain · doi:10.1093/brain/122.5.807 · Cited by 134
Self-citationHirota, N., Kaji, R., Bostock, H., Shindo, K., Kawasaki, T., Mizutani, K., Oka, N., Kohara, N., Saida, T., & Kimura, J. (1997) · Brain · doi:10.1093/brain/120.12.2159 · Cited by 132
Haemophilus influenzae infection and Guillain-Barre syndrome
Mori, M. (2000) · Brain · doi:10.1093/brain/123.10.2171 · Cited by 131
Ropper, A. H. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540190051014 · Cited by 126
Nagai, Y., Momoi, T., Saito, M., Mitsuzawa, E., & Ohtani, S. (1976) · Neuroscience Letters · doi:10.1016/0304-3940(76)90033-1 · Cited by 124
Yuki, N., Tagawa, Y., Irie, F., Hirabayashi, Y., & Handa, S. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00201-9 · Cited by 124
Salloway, S., Mermel, L. A., Seamans, M., Aspinall, G. O., Nam Shin, J. E., Kurjanczyk, L. A., & Penner, J. L. (1996) · Infection and Immunity · doi:10.1128/iai.64.8.2945-2949.1996 · Cited by 124
Ogawa‐Goto, K., Funamoto, N., Ohta, Y., Abe, T., & Nagashima, K. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb11018.x · Cited by 123
Acute paresis of extraocular muscles associated with IgG Anti‐GQ1b antibody
Yuki, N. (1996) · Annals of Neurology · doi:10.1002/ana.410390517 · Cited by 122
Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides.
O’Leary, C., Veitch, J., Durward, W. F., Thomas, A. M., Rees, J. H., & Willison, H. J. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.61.6.649 · Cited by 120
Self-citationThomas, F. P., Trojaborg, W., Nagy, C., Santoro, M., Sadiq, S. A., Latov, N., & Hays, A. P. (1991) · Acta Neuropathologica · doi:10.1007/bf00296548 · Cited by 117
Pestronk, A., & Choksi, R. M. (1997) · Neurology · doi:10.1212/wnl.49.5.1289 · Cited by 116
Willison, H. J., & Veitch, J. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90042-6 · Cited by 116
Self-citationPlasma exchange and intravenous immunoglobulin treatment of neuromuscular disease
Thornton, C. A., & Griggs, R. C. (1994) · Annals of Neurology · doi:10.1002/ana.410350304 · Cited by 115
Anti-MAG and anti-SGPG antibodies in neuropathy
van den Berg, L. H., Hays, A. P., Nobile‐Orazio, E., Kinsella, L. J., Manfredini, E., Corbo, M., Rosoklija, G. B., Younger, D. S., Lovelace, R. E., Trojaborg, W., et al. (1996) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199605)19:5<637::aid-mus12>3.0.co;2-k · Cited by 115
Association of IgG anti‐GD1a antibody with severe Guillain–Barré syndrome
Yuki, N., Yamada, M., Sato, S., Ohama, E., Kawase, Y., Ikuta, F., & Miyatake, T. (1993) · Muscle & Nerve · doi:10.1002/mus.880160610 · Cited by 114
Uncini, A., Santoro, M., Corbo, M., Lugaresi, A., & Latov, N. (1993) · Muscle & Nerve · doi:10.1002/mus.880160606 · Cited by 113
Localization of GM1 and GD1b antigens in the human peripheral nervous system
Kusunoki, S., Chiba, A., Tai, T., Tai, T., & Kanazawa, I. (1993) · Muscle & Nerve · doi:10.1002/mus.880160710 · Cited by 113
Acute conduction block in vitro following exposure to antiganglioside sera
Arasaki, K., Kusunoki, S., Kudo, N., & Kanazawa, I. (1993) · Muscle & Nerve · doi:10.1002/mus.880160603 · Cited by 112
Acute ophthalmoparesis (without ataxia) associated with anti-GQ1b IgG antibody
Yuki, N., Odaka, M., & Hirata, K. (2001) · Ophthalmology · doi:10.1016/s0161-6420(00)00420-6 · Cited by 112
GM1b is a new member of antigen for serum antibody in Guillain-Barre syndrome
Kusunoki, S., Iwamori, M., Chiba, A., Hitoshi, S., Arita, M., & Kanazawa, I. (1996) · Neurology · doi:10.1212/wnl.47.1.237 · Cited by 109
Anti-GT1a IgG in Guillain-Barre syndrome
Koga, M. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.6.767 · Cited by 108
Localization of GM1 and Gal(β1‐3)GalNAc antigenic determinants in peripheral nerve
Corbo, M., Quattrini, A., Latov, N., & Hays, A. P. (1993) · Neurology · doi:10.1212/wnl.43.4.809 · Cited by 107
Yuki, N., Taki, T., & Handa, S. (1996) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00142-7 · Cited by 106
Hao, Q., Saida, T., Kuroki, S., Nishimura, M., Nukina, M., Obayashi, H., & Saida, K. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00166-5 · Cited by 106
The syndrome of acute sensory neuropathy
Windebank, A. J., Blexrud, M. D., Dyck, P. J., Daube, J. R., & Karnes, J. L. (1990) · Neurology · doi:10.1212/wnl.40.4.584 · Cited by 105
Failure of anti‐GM1 IgG OR IgM to induce conduction block following intraneural transfer
Harvey, G. K., Toyka, K. V., Zielasek, J., Kiefer, R., Simonis, C., & Hartung, H. (1995) · Muscle & Nerve · doi:10.1002/mus.880180404 · Cited by 104
Buchwald, B., Weishaupt, A., Toyka, K. V., & Dudél, J. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00053.x · Cited by 103
Two patterns of clinical recovery in Guillain-Barré syndrome with IgG anti-GM1 antibody
Kuwabara, S., Asahina, M., Koga, M., Mori, M., Yuki, N., & Hattori, T. (1998) · Neurology · doi:10.1212/wnl.51.6.1656 · Cited by 102
Sumner, A. J., Saida, K., Saida, T., Silberberg, D. H., & Asbury, A. K. (1982) · Annals of Neurology · doi:10.1002/ana.410110506 · Cited by 101
Yuki, N., Kuwabara, S., Koga, M., & Hirata, K. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00180-x · Cited by 100
Anti‐gal‐C antibody in autoimmune neuropathies subsequent to mycoplasma infection
Kusunoki, S., Chiba, A., Hitoshi, S., Takizawa, H., & Kanazawa, I. (1995) · Muscle & Nerve · doi:10.1002/mus.880180407 · Cited by 98
Willison, H. J., O’Hanlon, G. M., Paterson, G., Veitch, J., Wilson, G., Roberts, M., Tang, T., & Vincent, A. C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118529 · Cited by 98
Self-citationYuki, N., Taki, T., Takahashi, M., Saito, K., Tai, T., Miyatake, T., & Handa, S. (1994) · Infection and Immunity · doi:10.1128/iai.62.5.2101-2103.1994 · Cited by 98
Predictive value of anti-GM1 ganglioside antibodies in neuromuscular diseases: a study of 180 sera
Adams, D., Küntzer, T., Burger, D., Chofflon, M., Magistris, M. R., Regli, F., & Steck, A. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90192-a · Cited by 97
Guillain-Barre syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a
Kaida, K., Kusunoki, S., Kamakura, K., Motoyoshi, K., & Kanazawa, I. (2000) · Brain · doi:10.1093/brain/123.1.116 · Cited by 96
Association of anti-GM2 antibodies in Guillain-Barré syndrome with acute cytomegalovirus infection
Irie, S., Saito, T., Kanazawa, N., Ogino, M., Nukazawa, T., Ito, H., Tamai, Y., & Kowa, H. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(96)00059-8 · Cited by 95
Koga, M., Yuki, N., Takahashi, M., SAITO, K., & Hirata, K. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00168-9 · Cited by 95
Anti-PMP22 antibodies in patients with inflammatory neuropathy
Gabriel, C. M., Gregson, N. A., & Hughes, R. A. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00269-6 · Cited by 94
Nerve, muscle, and neuromuscular junction electrophysiology at high temperature
Rutkove, S. B., Kothari, M. J., & Shefner, J. M. (1997) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199704)20:4<453::aid-mus8>3.0.co;2-9 · Cited by 93
Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain–Barré syndrome
Ang, C. W., Jacobs, B. C., Brandenburg, A. H., Laman, J. D., van der Meché, F. G. A., Osterhaus, A. D. M. E., & van Doorn, P. A. (2000) · Neurology · doi:10.1212/wnl.54.7.1453 · Cited by 91
Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barre syndrome.
Jacobs, B. C., van Doorn, P. A., Groeneveld, J. H., Tio‐Gillen, A. P., & van der Meché, F. G. A. (1997) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.6.641 · Cited by 91
Sensory neuropathy associated with monoclonal immunoglobulin M to GD1b ganglioside
Daune, G. C., Farrer, R. G., Dalakas, M. C., & Quarles, R. H. (1992) · Annals of Neurology · doi:10.1002/ana.410310621 · Cited by 90
Bollensen, E., Steck, A. J., & Schachner, M. (1988) · Neurology · doi:10.1212/wnl.38.8.1266 · Cited by 90
Ilyas, A. A., Li, S. C., Chou, D. K. H., Li, Y. T., Jungalwala, F. B., Dalakas, M. C., & Quarles, R. H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68935-5 · Cited by 89
Prendergast, M. M., Lastovica, A. J., & Moran, A. P. (1998) · Infection and Immunity · doi:10.1128/iai.66.8.3649-3655.1998 · Cited by 89 · cited 2×
“In other studies, the oligosaccharide structures of GM1, GD1a, GD3 and GT1a-like LPSs have been determined in other C.jejuni strains isolated from patients with GBS using similar methods (Aspinall et al., 1994; Prendergast et al., 1998).”
MethodYuki, N., Ho, T. W., Tagawa, Y., Koga, M., Li, C. Y., Hirata, K., & Griffin, J. W. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00056-8 · Cited by 87
Peripheral neuropathy associated with monoclonal IgM anti-Pr2 cold agglutinins.
Willison, H. J., Paterson, G., Veitch, J., Inglis, G., & Barnett, S. C. (1993) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.11.1178 · Cited by 87
Self-citationGangliosides and modulation of the function of neural cells.
Tettamanti, G., & Riboni, L. (1993) · PubMed · Cited by 87
Jacobs, B. C., Hazenberg, M. P., van Doorn, P. A., Endtz, H. P., & van der Meche, F. G. A. (1997) · Journal of Infectious Diseases · doi:10.1093/infdis/175.3.729 · Cited by 86
Antiganglioside antibodies in Guillain-Barre syndrome after a recent cytomegalovirus infection
Khalili-Shirazi, A., Gregson, N. A., Gray, I. A., Rees, J. H., Winer, J. B., & Hughes, R. A. (1999) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.3.376 · Cited by 86
The clinical and diagnostic role of anti‐GM1 antibody testing
Kornberg, A. J., & Pestronk, A. (1994) · Muscle & Nerve · doi:10.1002/mus.880170115 · Cited by 85
Rapidly progressive, predominantly motor Guillain-Barré syndrome with anti-GalNAc-GD1a antibodies
Ang, C. W., Yuki, N., Jacobs, B. C., Koga, M., Van Doorn, P. A., Schmitz, P. I. M., & Van Der Meché, F. G. A. (1999) · Neurology · doi:10.1212/wnl.53.9.2122 · Cited by 84
Ganglioside localization on myelinated nerve fibres by cholera toxin binding
Ganser, A. L., Kirschner, D. A., & Willinger, M. (1983) · Journal of Neurocytology · doi:10.1007/bf01153342 · Cited by 84
Mitsumoto, H., Sliman, R. J., Schafer, I. A., Sternick, C. S., Kaufman, B., Wilbourn, A. J., & Horwitz, S. J. (1985) · Annals of Neurology · doi:10.1002/ana.410170413 · Cited by 84
Special sensory ataxia in Miller Fisher syndrome detected by postural body sway analysis
Kuwabara, S., Asahina, M., Nakajima, M., Mori, M., Fukutake, T., Hattori, T., & Yuki, N. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199904)45:4<533::aid-ana19>3.0.co;2-h · Cited by 84
Conduction block in rat myelinated fibres following acute exposure to antigalactocerebroside serum
Lafontaine, S. R., Rasminsky, M., Saida, T., & Sumner, A. J. (1982) · The Journal of Physiology · doi:10.1113/jphysiol.1982.sp014073 · Cited by 83
Ataxic Guillain-Barré syndrome with anti-GQ1b antibody: Relation to Miller Fisher syndrome
Yuki, N., Susuki, K., & Hirata, K. (2000) · Neurology · doi:10.1212/wnl.54.9.1851 · Cited by 83
Pathogenesis of the neurotoxicity caused by anti-GD2 antibody therapy
Yuki, N., Yamada, M., Tagawa, Y., Takahashi, H., & Handa, S. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)05390-2 · Cited by 82
Yuki, N., Tagawa, Y., & Handa, S. (1996) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00042-2 · Cited by 82
Koga, M., Yuki, N., Ariga, T., Morimatsu, M., & Hirata, K. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00016-2 · Cited by 82
The CNS in Guillain-Barre Syndrome
Ropper, A. H. (1983) · Archives of Neurology · doi:10.1001/archneur.1983.04050070027003 · Cited by 81
RICHTER, R. B. (1962) · PubMed · Cited by 81
Marcus, D. M., Latov, N., Hsi, B. P., Gillard, B. K., Antel, J. P., Appel, S. H., Callegaro, L., Daune, G., Gillard, B. K., Latoy, N., et al. (1989) · Journal of Neuroimmunology · doi:10.1016/0165-5728(89)90144-6 · Cited by 80
Ilyas, A. A., Willison, H. J., Dalakas, M. C., Whitaker, J. N., & Quarles, R. H. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb01821.x · Cited by 79
Self-citationNeurology, E. P. I. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.2.218 · Cited by 79
Nishimura, M., Saida, T., Kuroki, S., Kawabata, T., Obayashi, H., Saida, K., & Uchiyama, T. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00106-2 · Cited by 78
Bovine gangliosides and acute motor polyneuropathy.
Figueras, A., Morales‐Olivas, F. J., Capellà, D., Palop, V., & Laporte, J. (1992) · BMJ · doi:10.1136/bmj.305.6865.1330 · Cited by 78
Yoneda, Y., Tokui, K., Hanihara, T., Kitagaki, H., Tabuchi, M., & Mori, E. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199906)45:6<736::aid-ana7>3.0.co;2-f · Cited by 78
Chapter 7 Gangliosides as modulators of neuronal calcium
Wu, G., & Ledeen, R. W. (1994) · Progress in brain research · doi:10.1016/s0079-6123(08)61942-1 · Cited by 77
Miller Fisher syndrome and Haemophilus influenzae infection
Koga, M., Yuki, N., Tai, T., & Hirata, K. (2001) · Neurology · doi:10.1212/wnl.57.4.686 · Cited by 76
Hirabayashi, Y., Nakao, T., Matsumoto, M., Obata, K., & Ando, S. (1988) · Journal of Chromatography A · doi:10.1016/s0021-9673(01)84550-7 · Cited by 75
O'Shannessy, D. J., Willison, H. J., Inuzuka, T., Dobersen, M. J., & Quarles, R. H. (1985) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(85)80024-2 · Cited by 75
Self-citationAnti‐GD1a ganglioside antibodies in peripheral motor syndromes
Carpo, M., Nobile‐Orazio, E., Meucci, N., Gamba, M., Barbieri, S., Allaria, S., & Scarlato, G. (1996) · Annals of Neurology · doi:10.1002/ana.410390417 · Cited by 75
Koski, C. L., Chou, D. K. H., & Jungalwala, F. B. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114152 · Cited by 75
Intravenous immunoglobulin therapy for Guillain-Barr� syndrome with IgG anti-GM1 antibody
Kuwabara, S., Mori, M., Ogawara, K., Hattori, T., Oda, S., Koga, M., & Yuki, N. (2001) · Muscle & Nerve · doi:10.1002/1097-4598(200101)24:1<54::aid-mus6>3.0.co;2-9 · Cited by 75
Gangliosides and Glycosphingolipids of Peripheral Nervous System Myelins—a Minireview
Ogawa‐Goto, K., & Abe, T. (1998) · Neurochemical Research · doi:10.1023/a:1022497114813 · Cited by 74
Patterns of reactivity of human anti‐GM1 antibodies with spinal cord and motor neurons
Corbo, M., Quattrini, A., Lugaresi, A., Santoro, M. M., Latov, N., & Hays, A. P. (1992) · Annals of Neurology · doi:10.1002/ana.410320402 · Cited by 74
Proposed Mechanism of Ataxia in Fisher's Syndrome
Ropper, A. H., & Shahani, B. T. (1983) · Archives of Neurology · doi:10.1001/archneur.1983.04050080037004 · Cited by 74
Hughes, R. A., Atkinson, P. F., Coates, P. J., Hall, S., & Leibowitz, S. (1992) · Muscle & Nerve · doi:10.1002/mus.880150506 · Cited by 74
Comparison of the muscle fiber diameter and satellite cell frequency in human muscle biopsies
Maier, F., & Bornemann, A. (1999) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199905)22:5<578::aid-mus5>3.0.co;2-t · Cited by 71
Yuki, N., Takahashi, M., Tagawa, Y., Kashiwase, K., Tadokoro, K., & Sairo, K. (1997) · Annals of Neurology · doi:10.1002/ana.410420107 · Cited by 71
Press, R., Matà, S., Lolli, F., Zhu, J., Andersson, T., & Link, H. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00580-9 · Cited by 70
Mechanisms of High-Dose Intravenous Immunoglobulins in Demyelinating Diseases
Stangel, M., Toyka, K. V., & Gold, R. (1999) · Archives of Neurology · doi:10.1001/archneur.56.6.661 · Cited by 70
Hao, Q., Saida, T., Yoshino, H., Kuroki, S., Nukina, M., & Saida, K. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199906)45:6<758::aid-ana10>3.0.co;2-n · Cited by 70
Growth factor stimulation triggers apoptotic cell death in mature oligodendrocytes
Muir, D., & Compston, D. A. S. (1996) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19960401)44:1<58::aid-jnr8>3.0.co;2-h · Cited by 69
Chronic motor neuropathies: Diagnosis, therapy, and pathogenesis
Kornberg, A. J., & Pestronk, A. (1995) · Annals of Neurology · doi:10.1002/ana.410370706 · Cited by 69
Acute cytomegalovirus infection and IgM anti-GM2 antibody
Yuki, N., & Tagawa, Y. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)00174-3 · Cited by 69
Mizoguchi, K., Hase, A., Obi, T., Matsuoka, H., Takatsu, M., Nishimura, Y., Irie, F., Seyama, Y., & Hirabayashi, Y. (1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.9.1121 · Cited by 69
Investigation of serum response to PMP22, connexin 32 and P0 in inflammatory neuropathies
Kwa, M., van Schaik, I. N., Brand, A., Baas, F., & Vermeulen, M. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00307-1 · Cited by 68
Gangliosides and bacterial toxins in Guillain-Barré syndrome
Willison, H. J., & Kennedy, P. G. E. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90239-u · Cited by 68
Self-citationLloyd, K. O., Gordon, C., Thampoe, I. J., & DiBenedetto, C. (1992) · PubMed · Cited by 67
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“In the latter instance rare human immune responses against the ganglioside-like structures can even result in serious illness, with the complement-fixing antibodies damaging peripheral nerves (Guillain-Barré syndrome) (990, 991).”
BackgroundHughes, R. A., & Cornblath, D. R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67665-9 · Cited by 1,676
Willison, H. J., Jacobs, B. C., & van Doorn, P. A. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00339-1 · Cited by 1,609
Self-citationGuillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis
van den Berg, B., Walgaard, C., Drenthen, J., Fokke, C., Jacobs, B. C., & van Doorn, P. A. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.121 · Cited by 1,101
Irani, S. R., Bera, K., Waters, P., Zuliani, L., Maxwell, S., Zandi, M. S., Friese, M. A., Galea, I., Kullmann, D. M., Beeson, D., et al. (2010) · Brain · doi:10.1093/brain/awq113 · Cited by 1,035
“, 2009) as clearly demonstrated, for instance, in patients with Guillain–Barré syndrome (Willison and Yuki, 2002).”
Metadata
- Authors
- Willison, H. J.
- Affiliations
- Southern General Hospital (GB)
- Corresponding author
- Willison, H. J.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-12-01
- Volume
- 125
- Issue
- 12
- Pages
- 2591-2625
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2021949020
- Cited by
- 710
- References
- 286
- Citations by year
- 2026: 10 · 2025: 13 · 2024: 19 · 2023: 22 · 2022: 16 · 2021: 21 · 2020: 19 · 2019: 12 · 2018: 20 · 2017: 23 · 2016: 34 · 2015: 30 · 2014: 37 · 2013: 32 · 2012: 33
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Clinical Neurology › Autoimmune Neurological Disorders and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- anti-glycolipid antibodies, peripheral neuropathy, Guillain-Barré syndrome, Miller Fisher syndrome, acute motor axonal neuropathy, gangliosides, GM1, GD1a, GQ1b, Campylobacter jejuni, molecular mimicry, sensory neuropathy, immunomodulatory therapy
- MeSH terms
- Animals, Autoantibodies, Glycolipids, Humans, Immunoglobulin G, Immunoglobulin M, Peripheral Nervous System Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.